Drug intelligence / Profile preview

shenxiang qiangxin decoction

Development stage: Unknown
Lead developer: Central Hospital of Shanghai Putuo District
Administration: Oral

Overview

Shenxiang Qiangxin Decoction is a traditional Chinese medicine (TCM) herbal formula developed by Putuo District Central Hospital in Shanghai. It is specifically formulated for the treatment of heart failure, particularly in patients exhibiting heart-kidney Yang deficiency syndrome according to TCM diagnostic criteria. The decoction aims to improve cardiac performance and alleviate clinical symptoms by tonifying Yang and strengthening the heart. It is currently being investigated in clinical trials to establish its efficacy and safety profile as a therapeutic intervention for chronic heart failure.

Other names: Shenxiang Qiangxin YinShenxiang Qiangxin Tang

Beyond the preview

Go deeper on shenxiang qiangxin decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenxiang qiangxin decoction.

Explore the full profile